← Leaderboards
William L Gerald
Sloan-Kettering Institute For Cancer Res
$10,319,111
Attributed
$10,319,111
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$10,319,111 · 9
By mechanism
U01$4,022,516 · 1
P30$2,432,906 · 2
P01$1,968,036 · 3
P50$1,895,653 · 3
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Pier Paolo Pandolfi$54,825,346
- Glenn Heller$7,155,475
- Jason A Koutcher$20,695,436
- Neal Rosen$21,048,001
- Steven M Larson$7,955,537
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseClassificationGene ExpressionTissuesMalignant NeoplasmsTumorMolecular GeneticsStagingProgramsHuman TissueSamplingImmunohistochemistryResearch PersonnelTissue SampleMemorial Sloan-Kettering Cancer CenterAndrogensHistopathologyFreezingParaffin EmbeddingFormalinAlgorithmsFundingMolecularBiomedical Facility
Grant awards (36)
Copy Number Alterations and Outcome Prediction In Early-Staga Prostate Cancer$218,633
P50 · FY2015 · CA · contact PI
Copy Number Alterations and Outcome Prediction In Early-Staga Prostate Cancer$216,489
P50 · FY2014 · CA · contact PI
DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING$217,485
P50 · FY2013 · CA · contact PI
DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING$230,681
P50 · FY2012 · CA · contact PI
PATHOLOGY$554,239
P30 · FY2011 · CA · contact PI
PATHOLOGY$573,929
P30 · FY2010 · CA · contact PI
DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING$204,803
P50 · FY2010 · CA · contact PI
Project 1$319,271
P01 · FY2009 · CA · contact PI
PATHOLOGY$292,678
P30 · FY2009 · CA · contact PI
DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING$215,739
P50 · FY2009 · CA · contact PI
Core A$165,527
P01 · FY2009 · CA · contact PI
Project 1$311,196
P01 · FY2008 · CA · contact PI
PATHOLOGY$292,642
P30 · FY2008 · CA · contact PI
DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING$249,950
P50 · FY2008 · CA · contact PI
Core A$162,010
P01 · FY2008 · CA · contact PI
Project 1$309,560
P01 · FY2007 · CA · contact PI
DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING$239,660
P50 · FY2007 · CA · contact PI
Core A$161,831
P01 · FY2007 · CA · contact PI
Project 1$178,709
P01 · FY2006 · CA · contact PI
DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING$102,213
P50 · FY2006 · CA · contact PI
Core A$93,815
P01 · FY2006 · CA · contact PI
Project 1$174,249
P01 · FY2005 · CA
Core A$91,868
P01 · FY2005 · CA
MOLECULAR CLASSIFICATION OF PROSTATE CANCER$232,043
U01 · FY2004 · CA
MOLECULAR CLASSIFICATION OF PROSTATE CANCER$977,375
U01 · FY2003 · CA
MOLECULAR CLASSIFICATION OF PROSTATE CANCER$927,687
U01 · FY2002 · CA
CORE--HUMAN TISSUE PROCUREMENT$157,506
P30 · FY2002 · CA
CORE--DNA ARRAY FACILITY$0
P50 · FY2002 · CA
CORE--DNA ARRAY FACILITY$0
P50 · FY2002 · CA
CORE--TUMOR PROCUREMENT AND PATHOLOGY$0
P01 · FY2002 · CA
MOLECULAR CLASSIFICATION OF PROSTATE CANCER$962,585
U01 · FY2001 · CA
CORE--HUMAN TISSUE PROCUREMENT$157,506
P30 · FY2001 · CA
CORE--DNA ARRAY FACILITY$0
P50 · FY2001 · CA
MOLECULAR CLASSIFICATION OF PROSTATE CANCER$922,826
U01 · FY2000 · CA
CORE--HUMAN TISSUE PROCUREMENT$246,900
P30 · FY2000 · CA
CORE--HUMAN TISSUE PROCUREMENT$157,506
P30 · FY2000 · CA